Next-Generation CDMO Downstream Processing: Overcoming Cross Contamination in Advanced ADC Manufacturing
Advanced CDMO Downstream Processing is driving a massive shift in the biopharmaceutical manufacturing market. Specifically, this critical purification phase is seeing a major paradigm change. Today, market gravity is moving away from simple bioreactor capacity. Instead, sophisticated next-generation processing is becoming the new standard. Therefore, manufacturing success now depends on purification rather than cultivation. For … Read more